Andra AP-fonden’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34M Buy
118,400
+16,300
+16% +$4.68M 0.47% 61
2025
Q1
$31.5M Buy
102,100
+35,500
+53% +$10.9M 0.52% 45
2024
Q4
$23.5M Buy
66,600
+5,500
+9% +$1.94M 0.38% 84
2024
Q3
$21.9M Buy
61,100
+26,000
+74% +$9.32M 0.32% 100
2024
Q2
$11.2M Buy
35,100
+1,900
+6% +$605K 0.19% 175
2024
Q1
$7.63M Sell
33,200
-2,300
-6% -$528K 0.14% 227
2023
Q4
$7.81M Buy
35,500
+1,100
+3% +$242K 0.41% 108
2023
Q3
$7.77M Sell
34,400
-900
-3% -$203K 0.46% 83
2023
Q2
$7.79M Buy
+35,300
New +$7.79M 0.2% 204
2019
Q2
Sell
-54,100
Closed -$6.35M 680
2019
Q1
$6.35M Buy
+54,100
New +$6.35M 0.18% 205
2018
Q3
$8.79M Sell
68,700
-8,000
-10% -$1.02M 0.23% 119
2018
Q2
$8.68M Buy
76,700
+5,900
+8% +$668K 0.23% 92
2018
Q1
$7.96M Buy
70,800
+58,200
+462% +$6.54M 0.21% 135
2017
Q4
$1.86M Sell
12,600
-3,100
-20% -$459K 0.04% 584
2017
Q3
$1.84M Sell
15,700
-11,200
-42% -$1.31M 0.04% 565
2017
Q2
$3.49M Sell
26,900
-10,000
-27% -$1.3M 0.09% 373
2017
Q1
$5K Buy
36,900
+14,200
+63% +$1.92K 0.12% 239
2016
Q4
$3.26M Sell
22,700
-2,300
-9% -$330K 0.09% 368
2016
Q3
$2.95M Sell
25,000
-6,300
-20% -$744K 0.08% 395
2016
Q2
$3.32M Buy
31,300
+9,700
+45% +$1.03M 0.08% 361
2016
Q1
$2.41M Buy
21,600
+7,800
+57% +$869K 0.06% 479
2015
Q4
$2.16M Sell
13,800
-6,400
-32% -$1M 0.06% 459
2015
Q3
$2.65M Sell
20,200
-1,600
-7% -$210K 0.08% 397
2015
Q2
$3.79M Buy
+21,800
New +$3.79M 0.11% 293